The CIHR Rare Disease Research Initiative, under the scientific leadership of the CIHR Institute of Genetics, and in partnership with the Government of Canada’s National Strategy for Drugs for Rare Diseases and the National Research Council – Human Health Therapeutics.


Share This

Select your desired option below to share a direct link to this page.
Your friends or family will thank you later.